Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphomaMICALLEF, Ivana N. M; MAURER, Matthew J; WITZIG, Thomas E et al.Blood. 2011, Vol 118, Num 15, pp 4053-4061, issn 0006-4971, 9 p.Article

Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphomaTHOMPSON, Carrie A; MAURER, Matthew J; CERHAN, James R et al.American journal of hematology. 2011, Vol 86, Num 12, pp 998-1000, issn 0361-8609, 3 p.Article

Expression of LM02 Is Associated With t(14;18)/ IGH-BCL2 Fusion but Not BCL6 Translocations in Diffuse Large B-Cell LymphomaDURNICK, David K; LAW, Mark E; MAURER, Matthew J et al.American journal of clinical pathology. 2010, Vol 134, Num 2, pp 278-281, issn 0002-9173, 4 p.Article

Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme : A North Central Cancer Treatment Group StudyGALANIS, Evanthia; JAECKLE, Kurt A; RICHON, Victoria M et al.Journal of clinical oncology. 2009, Vol 27, Num 12, pp 2052-2058, issn 0732-183X, 7 p.Article

A prospective study of quality of life in adults with newly diagnosed high-grade gliomas : The impact of the extent of resection on quality of life and survivalBROWN, Paul D; MAURER, Matthew J; LUNSFORD, L. Dade et al.Neurosurgery. 2005, Vol 57, Num 3, pp 495-504, issn 0148-396X, 10 p.Article

Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With ImmunochemotherapyMAURER, Matthew J; GHESQUIERES, Hervé; MOLINA, Thierry Jo et al.Journal of clinical oncology. 2014, Vol 32, Num 10, pp 1066-1073, issn 0732-183X, 8 p.Article

Tumorgrafts as In Vivo Surrogates for Women with Ovarian CancerWEROHA, S. John; BECKER, Marc A; FINK, Stephanie et al.Clinical cancer research (Print). 2014, Vol 20, Num 5, pp 1288-1297, issn 1078-0432, 10 p.Article

Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomasWITZIG, Thomas E; HUI TANG; NOWAKOWSKI, Grzegorz S et al.Blood. 2011, Vol 118, Num 18, pp 4882-4889, issn 0006-4971, 8 p.Article

Smoking, Alcohol Use, Obesity, and Overall Survival From Non-Hodgkin Lymphoma: A Population-Based StudyGEYER, Susan M; MORTON, Lindsay M; HARTGE, Patricia et al.Cancer. 2010, Vol 116, Num 12, pp 2993-3000, issn 0008-543X, 8 p.Article

Prospective study of quality of life in adults with newly diagnosed high-grade gliomasBROWN, Paul D; BALLMAN, Karla V; BUCKNER, Jan C et al.Journal of neuro-oncology. 2006, Vol 76, Num 3, pp 283-291, issn 0167-594X, 9 p.Article

Implantable cardioverter defibrillator implantation rates in the Olmsted County, Minnesota, Population: 1989-1999WU, Lambert A; KOTTKE, Thomas E; FRIEDMAN, Paul A et al.Journal of clinical epidemiology. 2002, Vol 55, Num 5, pp 458-461, issn 0895-4356Article

Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology ResourceLINK, Brian K; MAURER, Matthew J; COLGAN, Joseph P et al.Journal of clinical oncology. 2013, Vol 31, Num 26, pp 3272-3278, issn 0732-183X, 7 p.Article

Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patientsANSELL, Stephen M; MAURER, Matthew J; NOVAK, Anne J et al.American journal of hematology. 2012, Vol 87, Num 9, pp 865-869, issn 0361-8609, 5 p.Article

Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemiaMAURER, Matthew J; CERHAN, James R; SLAGER, Susan L et al.Blood. 2011, Vol 118, Num 10, pp 2821-2826, issn 0006-4971, 6 p.Article

Phase I and pharmacological study of cytarabine and tanespimycin in relapsed and refractory acute leukemiaKAUFMANN, Scott H; KARP, Judith E; MAURER, Matthew J et al.Haematologica (Roma). 2011, Vol 96, Num 11, pp 1619-1626, issn 0390-6078, 8 p.Article

A Phase 2 Study of Gemcitabine and Epirubicin for the Treatment of Pleural Mesothelioma : A North Central Cancer Treatment Study, N0021OKUNO, Scott H; DELAUNE, Robert; NORTHFELT, Donald W et al.Cancer. 2008, Vol 112, Num 8, pp 1772-1779, issn 0008-543X, 8 p.Article

A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphomaMICALLEF, Ivana N. M; KAHL, Brad S; MAURER, Matthew J et al.Cancer. 2006, Vol 107, Num 12, pp 2826-2832, issn 0008-543X, 7 p.Article

Utility of Progranulin and Serum Leukocyte Protease Inhibitor as Diagnostic and Prognostic Biomarkers in Ovarian CancerCARLSON, Aaron M; MAURER, Matthew J; GOERGEN, Krista M et al.Cancer epidemiology, biomarkers & prevention. 2013, Vol 22, Num 10, pp 1730-1735, issn 1055-9965, 6 p.Article

Prognostic Significance of Pretreatment Serum Cytokines in Classical Hodgkin LymphomaMARRI, Preethi Reddy; HODGE, Lucy S; MAURER, Matthew J et al.Clinical cancer research (Print). 2013, Vol 19, Num 24, pp 6812-6819, issn 1078-0432, 8 p.Article

Inherited genetic variation and overall survival following follicular lymphomaGIBSON, Todd M; WANG, Sophia S; ROTHMAN, Nathaniel et al.American journal of hematology. 2012, Vol 87, Num 7, pp 724-726, issn 0361-8609, 3 p.Article

A Polymorphism in the Complement Component C1qA Correlates with Prolonged Response Following Rituximab Therapy of Follicular LymphomaRACILA, Emilian; LINK, Brian K; WEINER, George J et al.Clinical cancer research (Print). 2008, Vol 14, Num 20, pp 6697-6703, issn 1078-0432, 7 p.Article

Prognostic significance of host immune gene polymorphisms in follicular lymphoma survivalCERHAN, James R; WANG, Sophia; LYNCH, Charles F et al.Blood. 2007, Vol 109, Num 12, pp 5439-5446, issn 0006-4971, 8 p.Article

Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme : A north central cancer treatment group study : Signal transductionGALANIS, Evanthia; HUCKNER, Jan C; FAECKLE, Kurt A et al.Journal of clinical oncology. 2005, Vol 23, Num 23, pp 5294-5304, issn 0732-183X, 11 p.Article

Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphomaCHARBONNEAU, Bridget; MAURER, Matthew J; DOGAN, Ahmet et al.American journal of hematology. 2012, Vol 87, Num 9, pp 880-885, issn 0361-8609, 6 p.Article

Expression of Myc, but not pSTAT3, is an adverse prognostic factor for diffuse large B-cell lymphoma treated with epratuzumab/R-CHOPGUPTA, Mamta; MAURER, Matthew J; WELLIK, Linda E et al.Blood. 2012, Vol 120, Num 22, pp 4400-4406, issn 0006-4971, 7 p.Article